Skip to main content

Table 6 Multivariate Cox regression analyses for the factors associated with overall survival

From: Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

 

OS

Variables

HR

95% CI

p-value

Initial clinical stage

3.597

1.037–12.480

0.044

ER

3.329

0.296–37.454

0.330

bcl-2

3.027

0.557–16.437

0.200

Triple negative

1.847

0.492–6.935

0.364